home > news > detailed info

Protagen Protein Services expands analytical Service Spectrum in Biosimilar Development Support

Protagen Protein Services

Faster, more accurate characterization of biomolecular stability using Differential Scanning Calorimetry

Heilbronn/Dortmund February 2019: The success or failure of the development of a biopharmaceutical product is also governed by protein stability. Protein stability is considered a critical parameter during manufacturing, production, formulation, long term storage, efficacy, and delivery to patients.
To meet our customer demands now and in the future, PPS always invests in new analytical technique and recently added a new Differential Scanning Calorimetry (DSC) device.

Now we can offer the DSC analysis requiring five times less sample amount. Furthermore we are able to state the temperature at which denaturation of the protein begins: T onset of melting. This additional information to the melting temperature of the protein domains provides further insights to the overall stability of the analyzed biotherapeutic drug.

The new method extends our capabilities to obtain additional complementary results, for demonstrating Biosimilarity and Batch-to-Batch Comparability for the benefit of our customers. As additional value it offers developers a quick stability assay to identify biotherapeutics with good stability potential and enables to determine the conditions that maximize the shelf-life of a biotherapeutic.

As we help to develop highly stable protein therapeutics the production of drugs will become more cost-effectively, may face fewer challenges during the manufacturing process, and they are more likely to remain functional during formulation and storage without any aggregation or alteration.

Besides the new DSC method it is outmost important to also analyze the protein research object with other stability indicating methods. Learn more from our broad analytical spectrum at

Key words: Biosimilars/protein analysis/drug development/analytical service

About Protagen Protein Services GmbH (PPS):

Protagen Protein Services (PPS) is a world leading CRO and recognized expert in mass spectrometry methods for analytical services in protein science. Over 20 years of market experience and the comprehensive spectrum of validated analytical methods ensure the highest quality for customers in the pharmaceutical, biotech and life science industry. PPS supports Biosimilar developers with a broad range of analytical methods and consulting in achieving and demonstrating Biosimilarity. For developing new biological entities (NBEs) PPS supports customer approaches by all-in-one-hand service with including full analytical support, complete documentation and outstanding project management to gain market success.


Tobias Timtner
Marketing Manager
Protagen Protein Services GmbH 
Inselwiesenstraße 10
74076 Heilbronn, Germany

Tel.: +49 7131 74504-0
Fax: +49 7131 74 504-299
phone +49 231 9742 61 00
email Protagen Protein Services (GmbH), Inselwiesenstraße 10, D-74076 Heilbronn
Print this page
Send to a friend
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

BioT ULT Transporter


The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

Industry Events

PPMA Total Show

1-3 October 2019, Birmingham

About PPMA Total Show PPMA Total is one of UK’s largest processing and packaging machinery exhibitions. Building on the success of the PPMA Show in 2018, PPMA Total returns to the NEC, Birmingham, on 1-3 October 2019 for another show-stopping event.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement